The Size of the Intraocular Lens Market in the Middle East & Africa is valued at USD 0.196 billion in 2023 and estimated to grow at a CAGR of 3.22%, to reach USD 0.229 billion by 2028 during the forecast period 2023 to 2028.
The increasing incidence of ophthalmic issues majorly drives the MEA intraocular lens market. In addition, the proliferation of cataracts in the geriatric population has created the demand for intraocular lenses. The high susceptibility to cataracts in the increasing group of patients is expected to drive market growth during the forecast period.
Also, the market is expected to grow further owing to the growing preference for high-end intraocular lenses for the treatment of optical conditions.
Furthermore, the fast and straightforward surgical procedure for the replacement process coupled with the rapid technological advancements in the healthcare industry, especially in South Africa and UAE, is projected to provide lucrative growth opportunities for the MEA IOL market.
Therefore, the increase in the diabetic population results in an increasing need for intraocular lenses. In addition, countries such as UAE and Saudi Arabia have a high diabetic population, significantly influencing the market growth.
The International Agency for the Prevention of Blindness (IAPB) introduces new ways to eliminate one of the world's leading causes for preventable blindness. In addition, regional government organizations are conducting ophthalmic camps and providing favorable reimbursement policies to raise awareness and help achieve the Vision 2022 target. As a result, the MEA intraocular lens market growth is expected to increase during the forecast period.
A few challenges are associated with intraocular lenses (IOL), namely the confusions and errors related to the application of intraocular lenses (IOL), which leads to most common postoperative complications and the significant errors related to poor implantation of the IOL, which limits its applications. In addition, the reimbursement provided for IOL implants is less well known and less adopted in developing economies.
This research report on the Middle East & Africa Intraocular Lens Market has been segmented and sub-segmented into the following categories
By Material:
By Type:
By End User:
By Country:
Geographically, the Middle East holds a significant share of the MEA intraocular lens market; this can be attributed to key market players in the region. In addition, the growing geriatric population and advanced health facilities contribute to the region's dominance.
Meanwhile, UAE intraocular lens market is expected to experience the fastest growth rate in the MEA region during the forecast period. The development of the health sector and the growing penetration of the leading players are vital factors. Further, the market is predicted to be driven by the increasing prevalence of cataracts, macular degeneration, and diabetic retinopathy in diabetic patients. In addition, increased health spending and government initiatives to increase awareness of cataracts are expected to contribute to regional growth.
South Africa intraocular lens market is expected to increase due to the growing preference for toric lenses, the increasing adoption of lasers for cataract surgeries, and healthcare awareness. In addition, several market players are present in the country, which would also contribute to the market growth. Therefore, it will account for overall market growth in Africa.
Furthermore, Saudi Arabia intraocular lens market is projected expected account for a promising share in the intraocular lens market. The market growth is driven by increasing healthcare spending, supportive government policies, and improving healthcare infrastructure.
KEY MARKET PLAYERS
Key Market Companies dominating the Middle East & Africa Intraocular Lens Market Profiled in the Report are Johnson & Johnson, Valeant, Carl Zeiss Meditec AG, Rayner, Alcon, Inc. (division of Novartis AG), EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical, Physiol s.a., Calhoun Vision Center, and Oculentis GmBH.,
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region